biospecimen banks

CPDR Patient Education Program

Helpful Resources

 

Agent Orange and Prostate Cancer

Veterans diagnosed with prostate cancer may qualify for service-connected disability compensation.
Information Sheet

 

Special Clinic at WRNMMC for Men with Prostate Cancer

The Center for Prostate Disease Research (CPDR) at Walter Reed National Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".
More Information

 

Patient Education Links

American Cancer Society
Website: Cancer.Org
Phone: 800-ACS-2345

National Cancer Institute
Website: Cancer.Gov
Phone: 800-4-CANCER

National Comprehensive Cancer Network
Website: www.nccn.com

Us TOO International Prostate Cancer Education and Support Network
Website: www.ustoo.org
Phone: 800-808-7866

American Urological Association
Website: www.urologyhealth.org
Phone: 800-828-7866

Prostate Cancer Research Institute
Website: www.prostate-cancer.org
Phne: 800-641-7274

 

Newsletters

Choices
Website: www.paactusa.org
Phone: 616-453-1477

PCRI Insights
Website: www.pcri.org
Phone: 310-743-2117

The John Hopkins Prostate Bulletin
Phone: 800-829-0422

Us TOO Hotsheets
Website: www.ustoo.org

WRNMMC Us TOO Newsletter
Website: cpdr.org
Phone: 301-319-2918

CURRENT EVENTS


September 29, 2014

Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

REDWOOD CITY, CA – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team of investigators under a cooperative research and development agreement with USU. This new large study reconfirmed the biopsy-based test's Genomic Prostate Score (GPS) as a predictor of adverse pathology at surgery and, for the first time, validated GPS as a strong independent predictor of a rise in prostate-specific antigen (PSA) following surgery (biochemical recurrence).

Read Full Article

 

WRNMMC UsToo!
Quarterly Guest Speakers

Dr. Valencia Clay
Palliative Care Physician, WRNMMC

Dr. Jerry Waddell
Psychologist and Program Director of the Palliative Care Service, WRNMMC

Presentation: "Quality of Life in Disease Progression"

Free and no registration required.

Date: Thursday, 6 November 2014
Time: 7-8:30 PM
Location: America Building, 2nd floor, Room 2525
(above the lab/pharmacy) and Fort Belvoir Community Hospital
(Oaks Pavilion, 1st floor, Room 332)
by videoteleconference.
Contact: COL (ret) Jane Hudak for more information at 301-319-2918 or
jane.l.hudak.ctr@health.mil

Read the NOVEMEBR 2014 Newsletter